scispace - formally typeset
Open AccessJournal ArticleDOI

The 2016 revision of the World Health Organization classification of lymphoid neoplasms

Reads0
Chats0
TLDR
The revision clarifies the diagnosis and management of lesions at the very early stages of lymphomagenesis, refines the diagnostic criteria for some entities, details the expanding genetic/molecular landscape of numerous lymphoid neoplasms and their clinical correlates, and refers to investigations leading to more targeted therapeutic strategies.
About
This article is published in Blood.The article was published on 2016-05-19 and is currently open access. It has received 5321 citations till now.

read more

Citations
More filters
Journal ArticleDOI

Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis

TL;DR: The cancer burden attributed to human papillomavirus showed the clearest relationship with country income level, and infection-attributable cancer incidence allows for refined geographic analyses and identification of populations with a high infection-associated cancer burden.
Journal ArticleDOI

2016 US lymphoid malignancy statistics by World Health Organization subtypes.

TL;DR: Estimates of the total numbers of US lymphoid neoplasm cases by subtype as well as a detailed evaluation of incidence and survival statistics are presented, which can offer clues regarding their etiology.
Journal ArticleDOI

Infection in Organ Transplantation

TL;DR: Transplant infectious disease remains a key to the clinical and scientific investigation of organ transplantation and application of quantitative molecular microbial assays and advanced antimicrobial therapies have advanced care.
Journal ArticleDOI

International Consensus Classification of Myeloid Neoplasms and Acute Leukemia: Integrating Morphological, Clinical, and Genomic Data.

TL;DR: The authors, a group with expertise in the clinical, pathologic and genetic aspects of these disorders, developed the International Consensus Classification (ICC), aimed at facilitating diagnosis and prognostication of these neoplasms, improving treatment of affected patients, and allowing the design of innovative clinical trials.
References
More filters
Journal ArticleDOI

Uncommon histiocytic disorders: Rosai-Dorfman, juvenile xanthogranuloma, and Erdheim-Chester disease.

TL;DR: Recent whole-exome sequencing of JXG cases did not show the BRAF-V600E mutation, although 1 patient had PI3KCD mutation, and other recurrent mutations of the MAP kinase andPI3K pathways have been described in ECD.
Journal ArticleDOI

Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics.

TL;DR: 5 patients presenting with lymphadenopathy whose first biopsies demonstrated nodular lymphoid proliferations containing scattered CD30+, CD15+, EBV+ Hodgkin and Reed-Sternberg–like cells, are reported to highlight how some F-PTCLs may closely mimic lymphocyte-rich classical Hodgkin lymphoma requiring careful assessment of the T cells before rendering the latter diagnosis.
Journal ArticleDOI

Dendritic cell and histiocytic neoplasms: biology, diagnosis, and treatment.

TL;DR: Dendritic cell and histiocytic cell neoplasms are rare hematological disorders with variable clinical presentations and prognoses; however, because many tumors have recently been recognized, their true incidence is uncertain.
Journal ArticleDOI

Post-transplant molecularly defined Burkitt lymphomas are frequently MYC-negative and characterized by the 11q-gain/loss pattern

TL;DR: A novel aberration manifested by a specific 11q-gain/loss pattern in two cases (3%) lacking the MYC translocation was detected in 15 MYC-negative high-grade B- cell lymphomas resembling BL and two cell lines derived from high- grade B-cell lymphomas.
Related Papers (5)